Infectious Disease Diagnostics Market Worth $23.4 billion by 2025.

The infectious disease diagnostics is expected to grow at a CAGR of 5.9% from 2018 to 2025 to reach $23.4 billion by 2025.

The growth of this market will be driven by factors such as the increasing prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing. However, the lack of unfavorable and inadequate reimbursement scenario may hamper the growth of this market to a certain extent.

Browse the in-depth report:

Immunodiagnostics accounted for the largest share of the infectious disease diagnostics market in 2018. This is owing to the increasing use of immunoassays in POC infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments. Immunodiagnostic technologies are majorly used for the detection of infectious diseases. Radioimmunoassay and Enzyme-Linked Immunosorbent Assay (ELISA) was the predominant techniques used for the diagnosis. Lower complexity, high-sensitivity, and its ease of use are the major factors contributed to the growth of the immunodiagnostic technology for the diagnosis of infectious diseases. However, polymerase chain reaction (PCR) segment is expected to grow significantly during the forecast period. Increasing adoption of the molecular diagnostic technology in place of antigen testing by immunoassays, increasing chances of detecting the minute amount of protein biomarkers with high specificity; and growing probability of detecting infectious diseases to mitigate the result with high accuracy is expected to drive the growth of the molecular diagnostic technology in the infectious disease diagnostics market.

Request sample report on

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, and the U.K.), Asia-Pacific (China, and Japan), Latin America, and Middle East & Africa. North America commanded the largest share of the ****** infectious disease diagnostics market in 2017, followed by Europe and the Asia Pacific. The highest share of North American region in the infectious disease diagnostics market is primarily attributed to the growing healthcare sector, increasing need to treat various infectious diseases, increasing healthcare expenditure, growing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and large number of patient population.

Asia Pacific region is expected to be the fastest growing geographic market for infectious disease diagnostics market with countries, such as China, Japan, India, and Singapore among others are being the largest contributors to the growth of the market. Additionally, rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage the growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services are expected to equally influence the overall growth of the infectious disease diagnostics market during the forecast period.

Contact Info:



Contact Sales- +1-646-781-8004

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.